RAC 2.20% $1.78 race oncology ltd

Ann: Quarterly Activity Report & Appendix 4C, page-35

  1. 3,837 Posts.
    lightbulb Created with Sketch. 652
    How difficult and expensive would it be for RAC to commission the authors of that diabetes 2 research to replicate their findings and expand on that research?

    Pre-clinical research is cheap, and those researchers are well set up to do follow-on research.

    RAC is not limited to just doing pre-clinical work in Wollongong and Newcastle universities….they can commission work
    from all over the world….they have the money in the bank and academic researchers are always desperate for research funds.

    ….

    the Diabetes 2 treatment field is enormous!

    Agile is the key word!


    Last edited by hotcongo: 28/01/22
 
watchlist Created with Sketch. Add RAC (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.